1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. AEGLEA BIOTHERAPEUTICS INC

Aeglea BioTherapeutics Inc

XNAS: AGLE

Watchlist

Portfolio

Share


Insider Trading disclosures for Aeglea BioTherapeutics Inc

The latest disclosure was made by Cameron Turtle in Aeglea BioTherapeutics Inc where a trade of 277,750 Stock Option (Right to Buy) done was reported to US exchanges on Feb. 1, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Cameron Turtle Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 277,750 277,750 - - Stock Option (Right to Buy)
King-Jones Heidy See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 63,000 63,000 - - Stock Option (Right to Buy)
Scott Burrows L. Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 70,000 70,000 - - Stock Option (Right to Buy)
Burrows L. Scott Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Dec 2023 134,953 134,953 (0%) 0% 0 Common Stock
W. Jeffrey Albers Director 22 Nov 2023 34,360 34,360 (0%) 0% 0 Common Stock
Albers Jeffrey W. Director 22 Nov 2023 859 0 - - Series A Preferred Stock
W. Jeffrey Albers Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Nov 2023 50,000 50,000 - - Stock Option (Right to Buy)
Magovcevic Ivana Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2023 1,950,000 1,950,000 - - Stock Option (right to buy)
Russell J. Cox Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2023 1,950,000 1,950,000 - - Stock Option (right to buy)
Alison F. Lawton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2023 1,950,000 1,950,000 - - Stock Option (right to buy)
Hunter C. Smith Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2023 1,950,000 1,950,000 - - Stock Option (right to buy)
Jonathan Alspaugh President and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2023 19,787,969 19,787,969 - - Employee Stock Option (right to buy)
Linda Neuman Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Feb 2023 550,000 550,000 - - Employee Stock Option (right to buy)
Michael Conick Hanley Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Feb 2023 500,000 500,000 - - Employee Stock Option (right to buy)
James Paul Kastenmayer General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Feb 2023 500,000 500,000 - - Employee Stock Option (right to buy)
Jonathan Alspaugh Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Feb 2023 640,000 640,000 - - Employee Stock Option (right to buy)
Jeffrey M. Goldberg Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Nov 2022 1,884,838 1,884,838 - - Employee Stock Option (right to buy)
Linda Neuman Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Nov 2022 25,000 25,000 - - Employee Stock Option (right to buy)
Marcio Souza Director Purchase of securities on an exchange or from another person at price $ 0.56 per share. 25 Aug 2022 90,000 90,000 (0%) 0% 0.6 50,472 Common Stock
Leslie Sloan Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Aug 2022 130,000 130,000 - - Employee Stock Option (right to buy)
Michael Conick Hanley Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Aug 2022 130,000 130,000 - - Employee Stock Option (right to buy)
James Paul Kastenmayer Interim CEO & General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Aug 2022 130,000 130,000 - - Employee Stock Option (right to buy)
Jonathan Alspaugh Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Aug 2022 130,000 130,000 - - Employee Stock Option (right to buy)
Michael Conick Hanley Chief Commercial Officer Purchase of securities on an exchange or from another person at price $ 0.71 per share. 08 Jun 2022 28,200 36,200 (0%) 0% 0.7 20,022 Common Stock
Magovcevic Ivana Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2022 43,000 43,000 - - Director Stock Option (right to buy)
V. Bryan Lawlis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2022 43,000 43,000 - - Director Stock Option (right to buy)
Russell J. Cox Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2022 43,000 43,000 - - Director Stock Option (right to buy)
Alison F. Lawton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2022 43,000 43,000 - - Director Stock Option (right to buy)
Sandesh Mahatme Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2022 43,000 43,000 - - Director Stock Option (right to buy)
Hunter C. Smith Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2022 43,000 43,000 - - Director Stock Option (right to buy)
Armen Shanafelt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2022 43,000 43,000 - - Director Stock Option (right to buy)
Marcio Souza Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2022 43,000 43,000 - - Director Stock Option (right to buy)
Anthony G. Quinn Director, President & CEO Purchase of securities on an exchange or from another person at price $ 2.34 per share. 16 Mar 2022 80,079 550,540 (1%) 0% 2.3 187,705 Common Stock
Anthony G. Quinn Director, President & CEO Purchase of securities on an exchange or from another person at price $ 1.93 per share. 11 Mar 2022 67,472 431,044 (1%) 0% 1.9 130,221 Common Stock
Anthony G. Quinn Director, President & CEO Purchase of securities on an exchange or from another person at price $ 2.06 per share. 11 Mar 2022 34,777 363,572 (1%) 0% 2.1 71,780 Common Stock
Anthony G. Quinn Director, President & CEO Purchase of securities on an exchange or from another person at price $ 1.86 per share. 11 Mar 2022 42,417 473,461 (1%) 0% 1.9 78,942 Common Stock
Jonathan Alspaugh Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 2.08 per share. 11 Mar 2022 75,000 165,372 (0%) 0% 2.1 156,000 Common Stock
Anthony G. Quinn Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Feb 2022 350,000 350,000 - - Employee Stock Option (right to buy)
Leslie Sloan Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Feb 2022 180,000 180,000 - - Employee Stock Option (right to buy)
Michael Conick Hanley Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Feb 2022 160,000 160,000 - - Employee Stock Option (right to buy)
Steven Weber VP, Controller&Princ Acctg Off Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Feb 2022 30,000 30,000 - - Employee Stock Option (right to buy)
Jonathan Alspaugh Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Feb 2022 170,000 170,000 - - Employee Stock Option (right to buy)
Anthony G. Quinn Director, President & CEO Purchase of securities on an exchange or from another person at price $ 3.70 per share. 09 Dec 2021 43,108 318,269 (1%) 0% 3.7 159,500 Common Stock
Anthony G. Quinn Director, President & CEO Purchase of securities on an exchange or from another person at price $ 3.75 per share. 09 Dec 2021 10,526 328,795 (1%) 0% 3.8 39,473 Common Stock
Armen Shanafelt Director Purchase of securities on an exchange or from another person at price $ 3.65 per share. 09 Dec 2021 14,685 150,000 (0%) 0% 3.6 53,600 Common Stock
Armen Shanafelt Director Purchase of securities on an exchange or from another person at price $ 3.65 per share. 09 Dec 2021 13,516 135,315 (0%) 0% 3.6 49,333 Common Stock
Armen Shanafelt Director Purchase of securities on an exchange or from another person at price $ 3.67 per share. 09 Dec 2021 121,799 121,799 (0%) 0% 3.7 446,759 Common Stock
Jonathan Alspaugh Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 3.72 per share. 09 Dec 2021 50,000 90,372 (0%) 0% 3.7 186,000 Common Stock
Hunter C. Smith Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Nov 2021 60,000 60,000 - - Director Stock Option (right to buy)
Jonathan Alspaugh Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 6.37 per share. 16 Aug 2021 9,780 9,780 (0%) 0% 6.4 62,275 Common Stock
Jonathan Alspaugh Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 6.72 per share. 16 Aug 2021 7,200 40,372 (0%) 0% 6.7 48,400 Common Stock
Jonathan Alspaugh Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 6.50 per share. 16 Aug 2021 23,392 33,172 (0%) 0% 6.5 151,985 Common Stock
Jonathan Alspaugh Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jul 2021 160,000 160,000 - - Employee Stock Option (right to buy)
Marcio Souza Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2021 60,000 60,000 - - Director Stock Option (right to buy)
Magovcevic Ivana Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2021 40,000 40,000 - - Director Stock Option (right to buy)
V. Bryan Lawlis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2021 40,000 40,000 - - Director Stock Option (right to buy)
Russell J. Cox Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2021 40,000 40,000 - - Director Stock Option (right to buy)
Alison F. Lawton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2021 40,000 40,000 - - Director Stock Option (right to buy)
Sandesh Mahatme Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2021 40,000 40,000 - - Director Stock Option (right to buy)
Armen Shanafelt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2021 40,000 40,000 - - Director Stock Option (right to buy)
Anthony G. Quinn Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Feb 2021 330,000 330,000 - - Employee Stock Option (right to buy)
Leslie Sloan Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Feb 2021 160,000 160,000 - - Employee Stock Option (right to buy)
Michael Conick Hanley Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Feb 2021 135,000 135,000 - - Employee Stock Option (right to buy)
Steven Weber VP, Controller&Princ Acctg Off Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Feb 2021 50,000 50,000 - - Employee Stock Option (right to buy)
Magovcevic Ivana Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2020 28,100 28,100 - - Director Stock Option (right to buy)
V. Bryan Lawlis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2020 28,100 28,100 - - Director Stock Option (right to buy)
Russell J. Cox Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2020 28,100 28,100 - - Director Stock Option (right to buy)
Suzanne L. Bruhn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2020 28,100 28,100 - - Director Stock Option (right to buy)
Sandesh Mahatme Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2020 28,100 28,100 - - Director Stock Option (right to buy)
Armen Shanafelt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2020 28,100 28,100 - - Director Stock Option (right to buy)
Anthony G. Quinn Director, President & CEO Purchase of securities on an exchange or from another person at price $ 4.75 per share. 30 Apr 2020 165,000 538,469 (1%) 0% 4.8 783,750 Common Stock
Anthony G. Quinn Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2020 301,000 301,000 - - Employee Stock Option (right to buy)
Charles N. York Chief Financial Officer and VP Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2020 126,000 126,000 - - Employee Stock Option (right to buy)
Leslie Sloan Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2020 100,000 100,000 - - Employee Stock Option (right to buy)
Michael Conick Hanley Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2020 25,000 25,000 - - Employee Stock Option (right to buy)
Madduri Ravin Rao Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2020 25,000 25,000 - - Employee Stock Option (right to buy)
Madduri Ravin Rao Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Nov 2019 130,000 130,000 - - Employee Stock Option (right to buy)
Michael Conick Hanley Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Oct 2019 130,000 130,000 - - Employee Stock Option (right to buy)
Anthony G. Quinn Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Oct 2019 662 0 - - Stock Option (right to buy)
Anthony G. Quinn Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.31 per share. 04 Oct 2019 17,603 371,908 (1%) 0% 6.3 111,075 Common Stock
Anthony G. Quinn Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.46 per share. 04 Oct 2019 662 354,305 (1%) 0% 5.5 3,615 Common Stock
Anthony G. Quinn Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Oct 2019 17,603 119,914 - - Stock Option (right to buy)
Anthony G. Quinn Director, President & CEO Purchase of securities on an exchange or from another person at price $ 6.23 per share. 12 Jun 2019 5,282 353,643 (1%) 0% 6.2 32,913 Common Stock
Anthony G. Quinn Director, President & CEO Purchase of securities on an exchange or from another person at price $ 6.17 per share. 12 Jun 2019 14,406 348,361 (1%) 0% 6.2 88,836 Common Stock
Anthony G. Quinn Director, President & CEO Purchase of securities on an exchange or from another person at price $ 6.11 per share. 12 Jun 2019 12,217 333,955 (1%) 0% 6.1 74,705 Common Stock
Anthony G. Quinn Director, President & CEO Purchase of securities on an exchange or from another person at price $ 6.56 per share. 20 May 2019 8,989 304,135 (1%) 0% 6.6 58,923 Common Stock
Anthony G. Quinn Director, President & CEO Purchase of securities on an exchange or from another person at price $ 6.86 per share. 20 May 2019 3,809 321,738 (1%) 0% 6.9 26,128 Common Stock
Anthony G. Quinn Director, President & CEO Purchase of securities on an exchange or from another person at price $ 6.89 per share. 20 May 2019 13,794 317,929 (1%) 0% 6.9 94,981 Common Stock
Anthony G. Quinn Director, President & CEO Purchase of securities on an exchange or from another person at price $ 6.83 per share. 15 May 2019 5,520 288,928 (0%) 0% 6.8 37,691 Common Stock
Anthony G. Quinn Director, President & CEO Purchase of securities on an exchange or from another person at price $ 7.10 per share. 15 May 2019 719 277,152 (0%) 0% 7.1 5,103 Common Stock
Anthony G. Quinn Director, President & CEO Purchase of securities on an exchange or from another person at price $ 6.76 per share. 15 May 2019 6,256 283,408 (0%) 0% 6.8 42,269 Common Stock
Anthony G. Quinn Director, President & CEO Purchase of securities on an exchange or from another person at price $ 6.65 per share. 15 May 2019 6,218 295,146 (1%) 0% 6.6 41,335 Common Stock
Leslie Sloan Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2019 36,000 36,000 - - Employee Stock Option (right to buy)
Anthony G. Quinn Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2019 280,000 280,000 - - Stock Option (right to buy)
Charles N. York Chief Financial Officer and VP Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2019 87,600 87,600 - - Employee Stock Option (right to buy)
James Wooldridge Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2019 50,200 50,200 - - Employee Stock Option (right to buy)
Aaron Schuchart Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2019 60,000 60,000 - - Employee Stock Option (right to buy)
Anthony G. Quinn Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.31 per share. 06 Feb 2019 7,433 276,433 (0%) 0% 6.3 46,902 Common Stock
Anthony G. Quinn Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Feb 2019 7,433 137,517 - - Stock Option (right to buy)
Anthony G. Quinn Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Feb 2019 1,323 662 - - Stock Option (right to buy)
Anthony G. Quinn Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.46 per share. 06 Feb 2019 1,323 269,000 (0%) 0% 5.5 7,224 Common Stock
Anthony G. Quinn Director, President & CEO Purchase of securities on an exchange or from another person at price $ 6.02 per share. 07 Dec 2018 2,000 94,793 (0%) 0% 6.0 12,040 Common Stock
Anthony G. Quinn Director, President & CEO Purchase of securities on an exchange or from another person at price $ 9.13 per share. 07 Dec 2018 994 95,787 (0%) 0% 9.1 9,075 Common Stock
Anthony G. Quinn Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.11 per share. 07 Dec 2018 150,000 245,787 (1%) 0% 4.1 616,500 Common Stock
Anthony G. Quinn Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.46 per share. 07 Dec 2018 3,306 249,093 (1%) 0% 5.5 18,051 Common Stock
Anthony G. Quinn Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.31 per share. 07 Dec 2018 18,584 267,677 (1%) 0% 6.3 117,265 Common Stock
Anthony G. Quinn Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Dec 2018 150,000 0 - - Director Stock Option (right to buy)
Anthony G. Quinn Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Dec 2018 3,306 1,985 - - Director Stock Option (right to buy)
Anthony G. Quinn Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Dec 2018 18,584 144,950 - - Director Stock Option (right to buy)
Aaron Schuchart Chief Business Officer Sale of securities on an exchange or to another person at price $ 9.50 per share. 27 Sep 2018 5,900 2,500 (0%) 0% 9.5 56,050 Common Stock
Aaron Schuchart Chief Business Officer Sale of securities on an exchange or to another person at price $ 9.55 per share. 27 Sep 2018 100 8,400 (0%) 0% 9.6 955 Common Stock
Aaron Schuchart Chief Business Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.50 per share. 17 Aug 2018 8,500 8,500 (0%) 0% 3.5 29,750 Common Stock
Aaron Schuchart Chief Business Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Aug 2018 8,500 91,500 - - Employee Stock Option (right to buy)
George Georgiou None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Aug 2018 20,000 10,000 - - Director Stock Option (right to buy)
George Georgiou None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Aug 2018 17,333 6,667 - - Director Stock Option (right to buy)
George Georgiou None Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.28 per share. 13 Aug 2018 17,333 155,861 (0%) 0% 7.3 126,184 Common Stock
George Georgiou None Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.73 per share. 13 Aug 2018 20,000 175,861 (0%) 0% 4.7 94,600 Common Stock
Anthony G. Quinn Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jul 2018 50,000 50,000 - - Employee Stock Option (right to buy)
Anthony G. Quinn Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jul 2018 75,000 75,000 - - Employee Stock Option (right to buy)
Anthony G. Quinn Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jul 2018 75,000 75,000 - - Employee Stock Option (right to buy)
Anthony G. Quinn Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jul 2018 300,000 300,000 - - Employee Stock Option (right to buy)
V. Bryan Lawlis None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jul 2018 36,800 36,800 - - Director Stock Option (right to buy)
Anthony G. Quinn Director, Interim CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Jul 2018 14,866 163,534 - - Director Stock Option (right to buy)
Anthony G. Quinn Director, Interim CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Jul 2018 24,000 0 - - Director Stock Option (right to buy)
Anthony G. Quinn Director, Interim CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.04 per share. 12 Jul 2018 24,000 77,927 (0%) 0% 7.0 168,960 Common Stock
Anthony G. Quinn Director, Interim CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.31 per share. 12 Jul 2018 14,866 92,793 (0%) 0% 6.3 93,804 Common Stock
Anthony G. Quinn Director, Interim CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.46 per share. 11 Jul 2018 3,307 53,927 (0%) 0% 5.5 18,056 Common Stock
Anthony G. Quinn Director, Interim CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Jul 2018 3,307 5,291 - - Director Stock Option (right to buy)
Russell J. Cox None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2018 18,400 18,400 - - Director Stock Option (right to buy)
Suzanne L. Bruhn None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2018 18,400 18,400 - - Director Stock Option (right to buy)
Sandesh Mahatme None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2018 18,400 18,400 - - Director Stock Option (right to buy)
George Georgiou None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2018 18,400 18,400 - - Director Stock Option (right to buy)
Armen Shanafelt Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2018 18,400 18,400 - - Director Stock Option (right to buy)
Magovcevic Ivana None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Mar 2018 36,800 36,800 - - Director Stock Option (right to buy)
Anthony G. Quinn Director, Interim CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2018 178,400 178,400 - - Employee Stock Option (right to buy)
Charles N. York Chief Financial Officer and VP Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2018 92,100 92,100 - - Employee Stock Option (right to buy)
James Wooldridge Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2018 45,000 45,000 - - Employee Stock Option (right to buy)
Aaron Schuchart Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2018 20,000 20,000 - - Employee Stock Option (right to buy)
Anthony G. Quinn Director, Interim CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.46 per share. 15 Feb 2018 15,211 50,620 (0%) 0% 5.5 83,052 Common Stock
Anthony G. Quinn Director, Interim CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Feb 2018 15,211 8,598 - - Director Stock Option (right to buy)
Anthony G. Quinn Director, Interim CEO Purchase of securities on an exchange or from another person at price $ 5.06 per share. 06 Dec 2017 600 35,409 (0%) 0% 5.1 3,039 Common Stock
Anthony G. Quinn Director, Interim CEO Purchase of securities on an exchange or from another person at price $ 4.99 per share. 06 Dec 2017 2,800 34,809 (0%) 0% 5.0 13,967 Common Stock
Anthony G. Quinn Director, Interim CEO Purchase of securities on an exchange or from another person at price $ 4.92 per share. 06 Dec 2017 4,888 32,009 (0%) 0% 4.9 24,072 Common Stock
Russell J. Cox None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2017 30,000 30,000 - - Director Stock Option (right to buy)
Anthony G. Quinn None Purchase of securities on an exchange or from another person at price $ 4.93 per share. 01 Dec 2017 5,065 27,121 (0%) 0% 4.9 24,976 Common Stock
Anthony G. Quinn None Purchase of securities on an exchange or from another person at price $ 4.98 per share. 01 Dec 2017 7,956 22,056 (0%) 0% 5.0 39,624 Common Stock
Anthony G. Quinn None Purchase of securities on an exchange or from another person at price $ 4.53 per share. 01 Dec 2017 4,100 14,100 (0%) 0% 4.5 18,578 Common Stock
Sandesh Mahatme None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2017 30,000 30,000 - - Director Stock Option (right to buy)
George Georgiou None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2017 30,000 30,000 - - Director Stock Option (right to buy)
Charles N. York Chief Financial Officer and VP Purchase of securities on an exchange or from another person at price $ 4.28 per share. 01 Dec 2017 2,000 12,828 (0%) 0% 4.3 8,568 Common Stock
Charles N. York Chief Financial Officer and VP Purchase of securities on an exchange or from another person at price $ 2.52 per share. 01 Dec 2017 1,959 14,787 (0%) 0% 2.5 4,929 Common Stock
Charles N. York Chief Financial Officer and VP Purchase of securities on an exchange or from another person at price $ 4.76 per share. 01 Dec 2017 10,241 34,787 (0%) 0% 4.8 48,700 Common Stock
Charles N. York Chief Financial Officer and VP Purchase of securities on an exchange or from another person at price $ 4.97 per share. 01 Dec 2017 3,259 24,546 (0%) 0% 5.0 16,197 Common Stock
Charles N. York Chief Financial Officer and VP Purchase of securities on an exchange or from another person at price $ 4.59 per share. 01 Dec 2017 6,500 21,287 (0%) 0% 4.6 29,855 Common Stock
Charles N. York Chief Financial Officer and VP Purchase of securities on an exchange or from another person at price $ 3.99 per share. 01 Dec 2017 2,000 10,828 (0%) 0% 4.0 7,974 Common Stock
Armen Shanafelt Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2017 30,000 30,000 - - Director Stock Option (right to buy)
Anthony G. Quinn Director, Interim CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Aug 2017 150,000 150,000 - - Employee Stock Option (right to buy)
Joseph E. Tyler VP, Manufacturing Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Aug 2017 25,000 25,000 - - Employee Stock Option (right to buy)
Scott W. Rowlinson VP, Research Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Aug 2017 25,000 25,000 - - Employee Stock Option (right to buy)
Charles N. York Chief Financial Officer and VP Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Aug 2017 58,500 58,500 - - Employee Stock Option (right to buy)
James Wooldridge Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Aug 2017 165,000 165,000 - - Employee Stock Option (right to buy)
James Wooldridge Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Aug 2017 10,000 10,000 - - Employee Stock Option (right to buy)
Aaron Schuchart Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Aug 2017 10,000 10,000 - - Employee Stock Option (right to buy)
Aaron Schuchart Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2017 100,000 100,000 - - Employee Stock Option (right to buy)
Anthony G. Quinn Director, interim Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Apr 2017 24,000 24,000 - - Employee Stock Option (right to buy)
Joseph E. Tyler VP, Manufacturing Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2017 39,000 39,000 - - Employee Stock Option (right to buy)
David G. Lowe Director, CEO and President Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2017 160,000 160,000 - - Employee Stock Option (right to buy)
Henry Hebel VP, Product Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2017 38,200 38,200 - - Employee Stock Option (right to buy)
Scott W. Rowlinson VP, Research Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2017 60,000 60,000 - - Employee Stock Option (right to buy)
Charles N. York Chief Financial Officer and VP Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2017 90,000 90,000 - - Employee Stock Option (right to buy)
Suzanne L. Bruhn None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2017 82,000 82,000 - - Director Stock Option (right to buy)
David G. Lowe Director, CEO and President Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2016 160,000 160,000 - - Employee Stock Option (right to buy)
Tyler E Joseph VP, Manufacturing Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2016 33,000 33,000 - - Employee Stock Option (right to buy)
Russell Cox None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2016 10,000 10,000 - - Director Stock Option (right to buy)
Sandesh Mahatme None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2016 10,000 10,000 - - Director Stock Option (right to buy)
Henry Hebel VP, Product Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2016 43,000 43,000 - - Employee Stock Option (right to buy)
George Georgiou None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2016 24,000 24,000 - - Director Stock Option (right to buy)
David G. Lowe Director, CEO and President 12 Apr 2016 2,857 0 - - Series A Preferred Stock
David G. Lowe Director, CEO and President 12 Apr 2016 2,801 0 - - Series B Preferred Stock
David G. Lowe Director, CEO and President 12 Apr 2016 5,658 5,658 - - Common Stock
Tyler E Joseph VP, Manufacturing 12 Apr 2016 22,857 0 - - Series A Preferred Stock
Tyler E Joseph VP, Manufacturing 12 Apr 2016 8,403 0 - - Series B Preferred Stock
Tyler E Joseph VP, Manufacturing 12 Apr 2016 31,260 42,428 - - Common Stock
Russell Cox None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 12 Apr 2016 7,000 7,000 - - Common Stock
Anthony G. Quinn None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 12 Apr 2016 10,000 10,000 - - Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters